Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,973 | -78,434 | -67,627 | -23,403 | -24,342 |
| Depreciation Amortization | 936 | 569 | 438 | 220 | 1,132 |
| Accounts payable and accrued liabilities | 33,993 | 38,127 | 35,168 | 538 | -2,919 |
| Other Working Capital | 38,203 | 41,153 | 41,100 | 6,622 | -1,827 |
| Other Operating Activity | -14,411 | -23,919 | -25,362 | 4,687 | -88,973 |
| Operating Cash Flow | $-32,252 | $-22,504 | $-16,283 | $-11,336 | $-116,929 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -581 | -80 | N/A | N/A | -103 |
| Investing Cash Flow | $-581 | $-80 | $N/A | $N/A | $-103 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 90 | 90 | 90 | 90 | 124,470 |
| Other Financing Activity | -329 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-239 | $90 | $90 | $90 | $124,470 |
| Beginning Cash Position | 128,574 | 128,574 | 128,574 | 128,574 | 121,136 |
| End Cash Position | 95,502 | 106,080 | 112,381 | 117,328 | 128,574 |
| Net Cash Flow | $-33,072 | $-22,494 | $-16,193 | $-11,246 | $7,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,252 | -22,504 | -16,283 | -11,336 | -116,929 |
| Capital Expenditure | -581 | -80 | N/A | N/A | -103 |
| Free Cash Flow | -32,833 | -22,584 | -16,283 | -11,336 | -117,032 |